Active Ingredient: ORPHENADRINE CITRATE
Proprietary Name: NORFLEX
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 30MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N013055
Product Number: 001
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: PAI HOLDINGS LLC DBA PHARMACEUTICAL ASSOCIATES INC
Marketing Status:
Discontinued
Patent and Exclusivity Information